OptimizeRx (OPRX) Total Current Liabilities (2010 - 2026)

OptimizeRx has reported Total Current Liabilities for 17 years, with the latest figure at $10.5 million in Q1 2026.

• Quarterly Total Current Liabilities fell 43.01% year-over-year to $10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 million (down 43.01% YoY) and the FY2025 annual result came in at $21.3 million, up 13.99% from the prior year.
• Total Current Liabilities slipped to $10.5 million in Q1 2026 per OPRX's latest filing, from $21.3 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $21.3 million in Q4 2025 and troughed at $5.5 million in Q2 2023.
• A 5-year average of $13.0 million and a median of $14.5 million in 2024 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2024 and 2026: Total Current Liabilities surged 171.45% in 2024, then slumped 43.01% in 2026.
• Over 5 years, Total Current Liabilities stood at $8.4 million in 2022, then soared by 112.99% to $17.9 million in 2023, then grew by 4.32% to $18.7 million in 2024, then advanced by 13.99% to $21.3 million in 2025, then tumbled by 50.81% to $10.5 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $10.5 million, $21.3 million, and $18.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.